<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-4WSB60OP</identifier><date>2016</date><creator>Koder, Barbara</creator><relation>documents/doc/4/URN_NBN_SI_doc-4WSB60OP_001.pdf</relation><relation>documents/doc/4/URN_NBN_SI_doc-4WSB60OP_001.txt</relation><format format_type="issue">2/3</format><format format_type="volume">67</format><format format_type="type">article</format><format format_type="extent">str. 141-150</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">30047015</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-4WSB60OP</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">arterijska hipertenzija</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">uporaba zdravil</subject><subject language_type_id="slv">zdravljenje</subject><title>The role of a pharmacist in optimizing antihypertensive drug therapy</title><title>Vloga farmacevta pri optimizaciji terapije z antihipertenzivi</title></Record>